COPD and cognitive impairment: the role of hypoxemia and oxygen therapy
- PMID: 20856825
- PMCID: PMC2939681
- DOI: 10.2147/copd.s10684
COPD and cognitive impairment: the role of hypoxemia and oxygen therapy
Abstract
Background: several studies have shown an association between chronic obstructive pulmonary disease (COPD) and cognitive impairment. These studies have been limited by methodological issues such as diagnostic uncertainty, cross-sectional design, small sample size, or lack of appropriate referent group. This study aimed to elucidate the association between COPD and the risk of cognitive impairment compared to referent subjects without COPD. In patients with established COPD, we evaluated the impact of disease severity and impairment of respiratory physiology on cognitive impairment and the potential mitigating role of oxygen therapy.
Methods: we used the Function, Living, Outcomes and Work (FLOW) cohort study of adults with COPD (n = 1202) and referent subjects matched by age, sex, and race (n = 302) to study the potential risk factors for cognitive impairment among subjects with COPD. Cognitive impairment was defined as a Mini-Mental State Exam score of <24 points. Disease severity was using Forced Expiratory Volume in one second (FEV(1)); the validated COPD Severity Score; and the BMI (Body Mass Index), Obstruction, Dyspnea, Exercise Capacity (BODE) Index. Multivariable analysis was used to control for confounding by age, sex, race, educational attainment, and cigarette smoking.
Results: COPD was associated with a substantive risk of cognitive impairment compared to referent subjects (odds ratio [OR] 2.42; 95% confidence interval [CI] 1.043-6.64). Among COPD patients, none of the COPD severity measures were associated with the risk of cognitive impairment (P > 0.20 in all cases). Low baseline oxygen saturation was related to increased risk of cognitive impairment (OR for oxygen saturation ≤88% (OR 5.45; 95% CI 1.014-29.2; P = 0.048). Conversely, regular use of supplemental oxygen therapy decreased the risk for cognitive impairment (OR 0.14; 95% CI 0.07-0.27; P < 0.0001).
Conclusion: COPD is a major risk factor for cognitive impairment. Among patients with COPD, hypoxemia is a major contributor and regular use of home oxygen is protective. Health care providers should consider screening their COPD patients for cognitive impairment.
Keywords: chronic obstructive pulmonary disease.
Figures

Similar articles
-
Assessment of cognitive impairment in long-term oxygen therapy-dependent COPD patients.Int J Chron Obstruct Pulmon Dis. 2015 Sep 29;10:2087-94. doi: 10.2147/COPD.S88326. eCollection 2015. Int J Chron Obstruct Pulmon Dis. 2015. PMID: 26491279 Free PMC article.
-
Clinical and radiographic correlates of hypoxemia and oxygen therapy in the COPDGene study.Respir Med. 2011 Aug;105(8):1211-21. doi: 10.1016/j.rmed.2011.02.015. Epub 2011 Mar 10. Respir Med. 2011. PMID: 21396809 Free PMC article. Clinical Trial.
-
Cognitive status among patients with chronic obstructive pulmonary disease.Int J Chron Obstruct Pulmon Dis. 2016 Mar 16;11:543-51. doi: 10.2147/COPD.S100850. eCollection 2016. Int J Chron Obstruct Pulmon Dis. 2016. PMID: 27042043 Free PMC article.
-
Long-Term Oxygen Therapy in COPD Patients Who Do Not Meet the Actual Recommendations.COPD. 2017 Jun;14(3):351-366. doi: 10.1080/15412555.2017.1319918. Epub 2017 May 16. COPD. 2017. PMID: 28506089 Review.
-
Oxygen therapy in advanced COPD: in whom does it work?Semin Respir Crit Care Med. 2010 Jun;31(3):334-42. doi: 10.1055/s-0030-1254073. Epub 2010 May 21. Semin Respir Crit Care Med. 2010. PMID: 20496302 Review.
Cited by
-
Changes in Spatial Working Memory in Stable Chronic Obstructive Pulmonary Disease: A Retrospective Study.Biomed Res Int. 2020 Jul 22;2020:7363712. doi: 10.1155/2020/7363712. eCollection 2020. Biomed Res Int. 2020. PMID: 32775438 Free PMC article. Clinical Trial.
-
Effect of 12-week pulmonary rehabilitation on cognitive function in patients with stable chronic obstructive pulmonary disease: study protocol for a single-center randomised controlled trial.BMJ Open. 2020 Oct 16;10(10):e037307. doi: 10.1136/bmjopen-2020-037307. BMJ Open. 2020. PMID: 33067278 Free PMC article.
-
Neurocognitive and behavioral abnormalities in Indian children with sleep-disordered breathing before and after adenotonsillectomy.Lung India. 2019 Jul-Aug;36(4):304-312. doi: 10.4103/lungindia.lungindia_398_18. Lung India. 2019. PMID: 31290415 Free PMC article.
-
Alterations of the default mode network and cognitive impairments in patients with chronic obstructive pulmonary disease.Int J Chron Obstruct Pulmon Dis. 2018 Feb 7;13:519-528. doi: 10.2147/COPD.S146870. eCollection 2018. Int J Chron Obstruct Pulmon Dis. 2018. PMID: 29445270 Free PMC article.
-
Protective effect of Dl-3n-butylphthalide on learning and memory impairment induced by chronic intermittent hypoxia-hypercapnia exposure.Sci Rep. 2014 Jul 3;4:5555. doi: 10.1038/srep05555. Sci Rep. 2014. PMID: 24990154 Free PMC article.
References
-
- Rodriguez Gonzalez-Moro JM, de Lucas Ramos P, Izquierdo Alonso JL, et al. Impact of COPD severity on physical disability and daily living activities: EDIP-EPOC I and EDIP-EPOC II studies. Int J Clin Pract. 2009;63:742–750. - PubMed
-
- Grant I, Prigatano GP, Heaton RK, McSweeny AJ, Wright EC, Adams KM. Progressive neuropsychologic impairment and hypoxemia. Relationship in chronic obstructive pulmonary disease. Arch Gen Psychiatry. 1987;44:999–1006. - PubMed
-
- Incalzi RA, Gemma A, Marra C, Muzzolon R, Capparella O, Carbonin P. Chronic obstructive pulmonary disease. An original model of cognitive decline. Am Rev Respir Dis. 1993;148:418–424. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical